- Home
- CAC vs CRMD Comparison
CAC vs CRMD Comparison
Compare CAC & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- CRMD
- Stock Information
- Founded
- CAC 1875
- CRMD 2006
- Country
- CAC United States
- CRMD United States
- Employees
- CAC N/A
- CRMD N/A
- Industry
- CAC Major Banks
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- CAC Finance
- CRMD Health Care
- Exchange
- CAC Nasdaq
- CRMD Nasdaq
- Market Cap
- CAC N/A
- CRMD 973.3M
- IPO Year
- CAC 1997
- CRMD 2010
- Fundamental
- Price
- CAC $43.34
- CRMD $11.62
- Analyst Decision
- CAC Hold
- CRMD Strong Buy
- Analyst Count
- CAC 3
- CRMD 7
- Target Price
- CAC $47.33
- CRMD $17.33
- AVG Volume (30 Days)
- CAC 56.5K
- CRMD 2.5M
- Earning Date
- CAC 07-29-2025
- CRMD 08-13-2025
- Dividend Yield
- CAC 3.88%
- CRMD N/A
- EPS Growth
- CAC 2.54
- CRMD N/A
- EPS
- CAC 3.09
- CRMD 0.28
- Revenue
- CAC $184,324,000.00
- CRMD $82,553,827.00
- Revenue This Year
- CAC $40.83
- CRMD $238.38
- Revenue Next Year
- CAC $5.29
- CRMD $53.52
- P/E Ratio
- CAC $14.04
- CRMD $41.86
- Revenue Growth
- CAC 13.26
- CRMD N/A
- 52 Week Low
- CAC $31.79
- CRMD $3.61
- 52 Week High
- CAC $50.07
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- CAC 71.29
- CRMD 39.52
- Support Level
- CAC $38.11
- CRMD $12.14
- Resistance Level
- CAC $40.92
- CRMD $17.43
- Average True Range (ATR)
- CAC 0.99
- CRMD 0.69
- MACD
- CAC 0.44
- CRMD -0.51
- Stochastic Oscillator
- CAC 99.26
- CRMD 4.60
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.